Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01457404 · ClinicalTrials.gov registry record · Phase 3
Integrated Cognitive Behavioral Therapy (ICBT) for Posttraumatic Stress Disorder (PTSD) and Substance Use Disorders
A Phase 3 study of Substance-Related Disorders and Stress Disorder, Post Traumatic, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT01457404: Completed Phase 3 study of Substance-Related Disorders and Stress Disorder, Post Traumatic, sponsored by Dartmouth-Hitchcock Medical Center.
NCT01457404 is a Phase 3 study of Substance-Related Disorders and Stress Disorder, Post Traumatic that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 56 participants, below the 1,520-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01457404, a Phase 3 study of Substance-Related Disorders and Stress Disorder, Post Traumatic, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the safety and practicality, feasibility and efficacy of ICBT for co-occurring PTSD and substance use disorders within the OEF/OIF/OND Veterans population, as delivered by routine clinicians at the Veterans Affairs.
Conditions Studied
Interventions
- BEHAVIORAL Treatment-as-usual
- BEHAVIORAL Integrated Cognitive Behavioral Therapy
Study Locations (1)
Rhode Island
- Providence Veterans Affairs Medical Center (PVAMC) - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2011-02 |
| Est. Completion | 2015-06 |
| Phase | Phase 3 |
What the finished NCT01457404 record still lists
NCT01457404 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,520-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Substance-Related Disorders appearing as the primary indexed condition, and to 2 interventions - of which Treatment-as-usual is the first listed.
NCT01457404 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT01457404 about?
NCT01457404 is a clinical study titled "Integrated Cognitive Behavioral Therapy (ICBT) for Posttraumatic Stress Disorder (PTSD) and Substance Use Disorders". The purpose of this study is to assess the safety and practicality, feasibility and efficacy of ICBT for co-occurring PTSD and substance use disorders within the OEF/OIF/OND Veterans population, as delivered by routine clinicians at the Veterans Affairs.
What is the current status of trial NCT01457404?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 56 participants. The study started on 2011-02. Estimated completion is 2015-06.
What conditions does trial NCT01457404 study?
This clinical trial studies the following conditions: Substance-Related Disorders, Stress Disorder, Post Traumatic.
What interventions are being tested in trial NCT01457404?
The interventions under investigation include: Treatment-as-usual (BEHAVIORAL), Integrated Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01457404?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01457404 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01457404's enrollment target sits among peer trials
56 41st of 58 higher than 18 of 58 other Substance-Related Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)
ACTIVE NOT RECRUITING · Phase 3
-
Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1
COMPLETED · Phase 3
-
Women's Treatment for Trauma and Substance Use Disorders - 1
COMPLETED · Phase 3
-
Cognitive Behavioral Therapy (CBT) for Posttraumatic Stress Disorder (PTSD) in Community Addiction Treatment
COMPLETED · Phase 3
-
Job-Seekers Training for Patients With Drug Dependence - 1
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia